On 24 June 1991 the ancient University of Milan hosted an international symposium on The Future of Medical Angiology. The participants were unanimous in their support for the concept of speciality recognition for angiology/vascular medicine but it became clear that such a goal is some way off for most of the countries
represented at the meeting. Of the European nations only Switzerland and Italy have speciality recognition. Switzerland and France have postgraduate training programmes and similar courses have been proposed in Germany. In other countries there is no formal postgraduate training or speciality recognition despite the fact that compelling arguments can be mustered to support such developments. Professor Boccalon from Toulouse proposed that angiology met the three requirements of a new speciality: (1) the disorders encompassed by the speciality are common; (2) they have a major effect on morbidity, mortality and quality of life; and (3) there were very real prospects for advances in our understanding of the disease processes as well as diagnosis and treatment that would need translating into clinical practice.
Although many subspecialities are currently involved with the clinical care of patients with specific vascular disorders, no one subspeciality currently covers the whole area. The need for close collaboration with other disciplines was emphasized by several speakers and the angiologist is perhaps best placed to co-ordinate such care.' In several countries diseases of the blood vessels come within the remit of the cardiologist but in practice the majority of cardiologists have no great experience of the management of these disorders. In the United States the situation may be changing for the better with both the American Heart Association and the American College of Cardiology mounting initiatives to enhance the attention paid to peripheral vascular diseases.
Speciality recognition means more than just co-ordinated and focused clinical care, for the specialists' role is also to research the subject and teach. To this classical triad might be added a responsibility for auditing and evaluating the process and outcome of clinical care in a critical manner. The interest of many would-be angiologists stems from their involvement in vascular research which has undergone a revolution in recent years with the growth of vascular biology and microvascular science. It is appropriate that a 'new' speciality should be prompted by such contemporary advances, yet retain the traditional values of older, well established disciplines. The question of education, both undergraduate and postgraduate, formed a central topic of the Milan symposium. Although many suggestions were put forward much work is needed for these to come to fruition. A working group will be established to define the curriculum for a Postgraduate European Fellowship in Vascular Medicine. Such an initiative will back up the efforts made by a working group of the International Union of Angiology who met in September 1990 with similar goals.
If the aims of the Milan symposium appear both laudable and logical we might ask why they have not been achieved already. What are the barriers to change? Both conservatism and vested interest undoubtedly play their part. Furthermore, it could be argued that because vascular diseases are diverse there is no one patient lobby (as, for example, in diabetes or those with renal failure) to effect changes in care . We should also accept that early angiological research was of dubious quality by contemporary standards thereby diminishing the standing of the subject. Nevertheless, barriers can be overcome and Milan was a successful step in the right direction. In some countries central authorities are adopting a more enlightened attitude: Dr Cooke from Stanford, California informed the audience that the United States' National Institute for Health had undertaken to support five vascular centres, a move which will surely further the development of the speciality in that country. If such initiatives flourish the future will surely be bright for vascular medicine to the benefit of patients.
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